y8 T celLs in the spleen and thymus and no other T lymphocytes. Immunization of these KN6-scid (H-2d, TLd) mice with 107 C57BL/6J ( MATERIALS AND METHODS Mice. The KN6 founder male has been described (9) . C57BL/6J (B6), BALB/c, B10.D2, B10.D2-H2dml, and A.TL mice were obtained from The Jackson Laboratories. CB.17-scid mice and the KN6 y8-scid mice were bred and maintained in the defined flora animal colony at the Ontario Cancer Institute (Toronto).
Antibodies and Cel Lines. The following monoclonal antibodies were used: biotinylated anti-KN6 (8D6) (10), biotinylated anti-C8 (GL3) (PharMingen), anti-CD3 (145-2C1l) [ Labeling of Donor Cells with FITC. In some experiments, persistence ofdonor cells was determined by directly labeling cells before injection into recipient mice, as has been previously described (16) .
RESULTS
Production and Characterization of KN6-scid Mice. The KN6-scid mouse was produced by breeding a KN6 male to a C.B-17-scid female reconstituted with C.B-17 bone marrow.
Offspring carrying the KN6 transgene were identified by PCR analysis of tail DNA, using primers specific for V$ and J'yl as described elsewhere (17) . These mice underwent a second round of breeding to scid animals, and offspring homozygous for the scid mutation were identified by the absence of serum immunoglobulin. Mice that were both KN6+ and immunoglobulin-negative were intercrossed through three more gen- (5) or the lack of ySy T cells in the periphery of C.B-17-scid mice transgenic for the V-y5/V81 receptor from an epidermal y8 T-cell clone (18) ing in the spleen at this time is about 1.5% (Fig. 3) spleen cells did not proliferate in vivo in response to a second challenge with 107 B6 spleen cells (Fig. 1) , implying that day 12 cells were also unresponsive in vivo. Since addition of IL-2 reverses the anergy observed in a3 T clones stimulated with antigen alone (21), we tested the ability of IL-2 to restore the responsiveness of 'y6 T cells from antigen-stimulated KN6-scid mice. Addition of IL-2 to MLR cultures had no effect on proliferation except for cells taken 19 days after immunization, when IL-2 restored the response to 50%o of the control response (Table 1) ; the recovery at that time may be due to the emergence of newly produced y8T cells from the thymus.
Thymocytes examined 14 days after injection of B6 spleen cells show normal reactivity to B6 spleen cells (Table 1 ), indicating that the proliferative anergy occurs only in the peripheral immune system. Anti-CD3 antibodies and Con A both activated normal 'y8
T cells from KN6-scid mice but had no effect on y6T cells from KN6-scid mice exposed previously to B6 cells ( A decrease in TCR density has been observed in some systems of peripheral tolerance (22, 23) but not in others (24) . In our experiments the TCR densities of responsive and nonresponsive KN6+ cells were identical, and there were no excess CD3+ or Thy 1.2+ cells that might represent y8T cells with their TCR down-regulated.
Stimulation of y8T cells from normal KN6-scid mice with B6 spleen cells in vitro for 4 days demonstrated high cytotoxicity against P815 mastocytoma cells in an antibodyredirected cytotoxicity assay (14) ( Table 2 ). In contrast, the same number of KN6+ cells taken from animals immunized 2 weeks earlier with B6 spleen cells did not develop cytotoxicity after a similar period of in vitro stimulation. Moreover, these cells were not constitutively cytotoxic nor could they be stimulated in vivo to exhibit cytotoxicity ( Table 2) . We conclude that, in addition to developing proliferative anergy, y5T cells also lose their cytotoxic ability during an immune response.
Primed yV T Cells Mediate Rejection of Aflogeneic Cells in
an Antigen-Specific Manner. We next examined the fate ofthe B6 donor cells in stimulated mice. If the KN6+ y8T cells in immunized mice are functionally anergic, the response to a second challenge should be similar to the response of C.B-17-scid mice, which lack any detectable T cells. Four days after primary injection of 107 B6 spleen cells into KN6-scid mice, the total number of persisting allogeneic B6 cells was Y4 of that in similarly challenged C.B-17-scid mice (Fig. 3) ; donor B6 cells were undetectable in KN6-scid recipients 7 days after their injection. However, a secondary challenge with B6 spleen cells of KN6-scid mice, 14 days after they were initially stimulated with B6 cells, was rejected much more strongly than the primary challenge (Fig. 3) . B6 spleen cells could barely be detected in mice 4 days after a secondary challenge.
This rapid clearance should be antigen specific if it is mediated by previously stimulated KN6+ y8 T cells. Alter- Net incorporation is the difference in incorporation between the B6-stimulated KN6+ yB T cells and the nonstimulated cells.
natively, this elimination may occur nonspecifically through previously activated natural killer (NK) cells or macrophages. Our experiments indicate that the rejection of allogeneic lymphocytes by KN6-scid mice is antigen specific. Like BALB/c spleen cells, spleen cells from B10.D2 (H2d, TLd), B10.D2-H2dm1, and A.TL (H2KSDd, TLd) mice do not stimulate KN6+ cells (Table 1) . Upon injection into KN6-scid mice previously injected with B6 spleen cells, none of these spleen cells are rejected (Fig. 3) .
The (31) , and memory probably depends on an increased number of another population of specific cytotoxic precursor cells (32) .
Memory helper a(3 T cells proliferate much more rapidly in response to antigenic stimulation than previously unstimulated cells (32) has not yet been identified.
